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Multiple  sclerosis  (MS) l  is  a  chronic  demyelinating  disease  of the  central 
nervous system (CNS) which can have a highly variable clinical course. While the 
etiology of this  disorder  is  unknown,  the  majority of current  research  in  this 
field is focussed on the elucidation of an infectious agent, an autoimmune process, 
or a  combination of the two (1, 2).  Numerous studies (1-4) have demonstrated 
immune  abnormalities  in  MS.  However,  the  majority  of these  reports  have 
employed assays that either measured an aspect of cellular recognition without 
consideration of function (eg. lympboproliferative assays), or assessed the func- 
tion of antigen-nonspecific  cell activity, such as natural  killer (NK) cell activity. 
Little is known of those populations of cells that are antigen-specific and have a 
demonstrable function, such as cytotoxic T  cells (CTL) or T  helper cells, which 
regulate T  or B cell functions. 
Measles  virus  has  been  considered  as  a  possible  etiological  factor  in  the 
pathogenesis of MS, based primarily on serological findings (5-8). For the most 
part,  assays designed to demonstrate  a  functional  cellular immune response  to 
this agent (eg. CTL) have been unsuccessful, and consequently, the assessment 
of such antigen-specific immune responses in MS patients has not been possible. 
Using T  cell clones (9,  10) and  bulk culture populations  (lacobson,  S.,  M.  L. 
Flerlage, and H. F. McFarland, manuscript in preparation) 2, we have shown that 
measles virus-specific CTL have a cell surface phenotype that was OKT4 +, and 
that they lysed infected cells by recognition of measles virus antigen in association 
with  HLA class  II  molecules.  To  determine  whether  a  measles  virus-specific 
cellular immune abnormality is associated with MS, we analyzed the capacity of 
lymphocytes from MS patients to generate measles virus-specific CTL. In com- 
parison,  we have studied normal  individuals and other disease controls (ODC). 
The vast majority of MS patients either failed to generate measles virus-specific 
CTL, or had significantly lower CTL responses than  either normal individuals 
or ODC. Moreover, this decreased CTL response in MS patients was specific for 
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measles  virus,  since  all  three  groups  generated  equivalent  CTL  responses  to 
influenza  virus.  These  results  suggest  that  a  measles  virus-specific  immune 
abnormality exists in MS. 
Materials  and  Methods 
Patient Profiles.  Patients  included  in  this  study  were  evaluated  in  the  MS  clinic, 
Neuroimmunology Branch, NIH. Each patient had a diagnosis of clinically definite  MS. 
14 of the 16 patients had a chronic progressive form of disease. Degree of disease activity 
is indicated in Table I. Disability was established using the Kurtzke Disability Scale (DSS). 
All MS patients were ambulatory. 5 of the  16 MS patients and 4 of the 13 ODC patients 
required  assistance  for ambulation.  None of the patients  had received steroid or other 
immunosuppressive treatment for at least 2 mo before being studied. Control individuals 
were participants  in the normal volunteer program.  The procedures used in this study 
were reviewed and  approved  by the  human  research  subpanel.  Informed consent  was 
obtained from each individual participating in the study. 
Lymphocyte Preparation.  Lymphocytes were  obtained  from  MS patients  and  normal 
individuals by leukopheresis,  and they were purified by density gradient centrifugation 
using  Ficoll-diatrizoate  (LSM  solution,  Litton  Bionetics  Inc.,  Charleston,  SC).  Venous 
blood  was  obtained  from  ODC,  and  was  drawn  in  preservative-free  heparin  (Abbott 
Laboratories, Irving, TX). Lymphocytes were frozen in cryopreservative media (12-132A, 
M. A. Bioproducts, Walkersville, MD) in a programmable cell freezer (Cryomedics, Inc., 
Bridgeport CT), and were stored in liquid nitrogen vapor until used. 
Cytotoxic Assay.  Peripheral  blood lymphocytes (PBL) were stimulated  with either the 
Edmonston strain of measles virus at a  multiplicity of infection (moi) of one, a  1:1,000 
dilution of influenza virus A/Bangkok/1/79-RX73 (H3N2), with a titer of 256 hemagglu- 
tinating units per milliliter, or media alone for 90 min in a humidified 5% CO~ incubator. 
Cells were cultured for 7 d  in RPMI  1640 (Gibco Laboratories, Grand Island, NY) plus 
5% human AB serum. Effectors were harvested and incubated with 5~Cr-labelled targets 
at a ratio of 40:1 for 5 h. Mean percent lysis was calculated as: (SICr-release with sensitized 
effectors -  spontaneous release) ×  100/(detergent release -  spontaneous release).  Mean 
percent  specific  lysis  was calculated  as the  mean  lysis  of sensitized  lymphocytes minus 
mean lysis of unsensitized lymphocytes on the appropriate virus-infected autologous target. 
The  mean  percent  lysis  of measles  virus-infected  targets  by unsensitized  iymphocytes 
from all three groups were comparable, and not statistically significant between groups: 
MS,  5.3  +  5.9%;  Normals,  3.5  __- 3.1%;  ODC,  1.8  +  2.6%.  Epstein-Barr  virus (EBV)- 
transformed B cell lines were generated for each individual. For targets, autologous EBV- 
transformed lymphoblastoid cell lines were infected with the Edmonston strain of measles 
virus  at  an  moi  of one  for  90  min,  and  incubated  for  4  d  in  RPMI  1640  media 
supplemented  with  glutamine  and antibiotics  plus  20%  fetal  calf serum.  For influenza 
virus-infected  targets,  autologous  B  cell  lines  were  infected  as  described  (9).  Effect- 
or/target ratios for all experiments are at 40:1. Spontaneous release from 51-Cr-labelled 
infected and uninfected targets ranged from 10 to 15%. Mean percent lysis of uninfected 
targets  by  sensitized  lymphocytes  from  all  three  groups  were  comparable,  and  not 
statistically significant between groups; MS, 6.6 +  6.7%, Normals, 7.7 _+ 3.3%, ODC, 5.7 
+  4.7%.  NK  activity  was  measured  by  the  cytolytic activity  of measles  virus-primed 
lymphocytes on the NK-sensitive target, K562. Values are expressed as means of triplicate 
cultures. 
Cold-target Blocking Experiments.  CTL were generated  from normal control  17  and 
MS patient 8 by stimulation with measles virus, as described above. After 7 d of incubation, 
cells were harvested, and 4 x  105 effectors were incubated with  104 51Cr-labelled measles 
virus-infected  autologous  B  cell  targets  (group  without  cold  blockers  in  Fig.  2)  in  a 
standard 5-h 5~Cr-release assay. Effectors were also incubated with a mixture of increasing 
amounts of unlabelled (cold) autologous infected and uninfected B cell targets to a constant 
number (104)  5~Cr-labelled (hot) measles virus-infected targets.  The data are plotted as Characteristics 
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TABLE  I 
of Patients and Controls in Study Population 
841 
Patient  Age  Sex  DSS  Disease activity  Course 
MS patients 
1  30  F  3  Remission 
2  23  F  4  Remission 
3  28  F  6  Active 
4  38  M  6  Active 
5  24  M  6  Active 
6  28  F  4  Active 
7  46  F  4  Stable 
8  45  F  5  Stable 
9  33  M  5  Active 
10  33  F  3  Stable 
11  49  M  4  Stable 
12  38  M  4  Stable 
13  39  M  4  Active 
14  50  F  5  Stable 
15  44  F  3  Stable 
16  55  M  4  Stable 
ODC patients 
Disease 
1  22  F  Myasthenia Gravis 
2  42  M  Myasthenia Gravis 
3  19  F  Myasthenia Gravis 
4  50  M  Spinal cerebellar degeneration 
5  52  F  Spinal cerebellar degeneration 
6  50  F  Spinal cerebellar degeneration 
7  44  M  Multisystem degeneration 
8  37  F  Multisystem degeneration 
9  37  F  Rheumatoid Arthritis 
10  23  F  Charcot-Marie Tooth 
11  35  M  Peripheral neuropathy 
12  43  M  Guillain-Barr~ syndrome 
13  59  M  Amyotrophic Lateral Sclerosis 
Healthy controls 
1  33  M 
2  41  M 
3  42  M 
4  32  M 
5  39  M 
6  26  M 
7  31  F 
8  38  F 
9  22  M 
10  28  F 
11  28  F 
12  36  M 
13  35  F 
14  44  M 
15  41  F 
16  25  F 
17  28  M 
Relapse-remit 
Relapse-remit 
Rapid progress 
Rapid progress 
Rapid progress 
Chronic progress 
Chronic progress 
Chronic progress 
Chromc progress 
Chromc progress 
Chronic progress 
Chromc progress 
Chronic progress 
Chronic progress 
Chromc progress 
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percent specific lysis vs. increasing amounts of cold/hot targets. Values are expressed as 
means of triplicate cultures. 
Statistical Analysis.  Statistics were performed by the student t test and the p values are 
reported with a two-tailed analysis. Results are expressed as means 4- SEM. 
Resu|ts 
Generation of  Measles and Influenza Virus-specific CTL.  The ability to generate 
measles virus and influenza virus-specific CTL was studied in MS patients, ODC, 
and normal individuals. The level of NK activity after measles virus stimulation 
was also examined. These results are shown in Fig.  1. Normal individuals whose 
PBL were  stimulated with  influenza virus  lysed their influenza virus-infected 
autologous B cell line at a group mean level of 47.0 4- 2.36% specific lysis (at an 
effector/target ratio of 40:1). MS patients and ODC generated comparable levels 
of influenza virus-specific  CTL responses,  with a  group  mean specific lysis of 
43.12  4-  3.3%,  and  42.3  4-  3.64%,  respectively  (Fig.  1B).  There  was  not  a 
significant difference between the ability of MS patients to generate influenza 
virus-specific CTL and that of normals or ODC (p >  0.8). 
In  contrast,  the  capacity  of MS  patients  to  generate  measles  virus-specific 
CTL, compared to either normal individuals or ODC was markedly diminished. 
The measles virus-specific CTL response for the normal group, as assayed on 
measles virus-infected autologous B  cell lines was  26.9  +  2.86%  specific lysis. 
ODC gave a  comparable level of lysis, with a group mean level of 26.7 4- 2.8% 
specific  lysis.  PBL  stimulated with  measles  virus  from  MS  patients,  however, 
lysed their measles virus-infected autologous B cell line at a group mean level of 
only 6.0  4-  1.4%  specific  lysis (Fig.  1A).  This  measles  virus-specific  lysis was 
significantly lower in the MS group than in normal individuals (p <  0.00001) or 
ODC  (p <  0.00001).  All  MS patients were  tested at least twice, and repeated 
samples from selected individuals gave similar low measles virus-specific CTL 
responses. These findings indicated that the depressed cytolytic responses from 
MS  patients  were  measles  virus-specific,  and  did not represent  a  generalized 
decrease in CTL. 
Previous  studies  (9,  10)  have  shown  that  measles  virus-specific  CTL  were 
virus- and HLA class II-restricted. To eliminate the possibility that the differ- 
ences in measles virus-specific CTL from MS patients was due to changes in NK 
activity, we compared the capacity of measles virus-stimulated lymphocytes from 
MS patients,  normal  individuals, and ODC  to  lyse the  K562  cell  line (Fig.  1). 
Measles virus-stimulated NK activity from MS patients had a  group mean level 
of lysis of 51.3  4- 5.0%.  Measles virus-stimulated NK activity from normals or 
ODC had group mean levels of lysis of 54.1  4- 3.7% and 46.5  4- 3.4%,  respec- 
tively. There was no statistically significant difference between the MS and the 
normal or ODC groups (p >  0.8). These results further substantiate the assertion 
that the lowered  measles virus-specific  CTL responses  of MS patients do  not 
reflect a generalized depressed cytolytic activity. 
Cold-target Blocking Experiments.  Measles virus-stimulated PBL from MS pa- 
tients 5,  8,  and  9  (Fig.  1 A, asterisks)  had significantly higher levels of lysis of 
measles  virus-infected  autologous  B  cell  lines  (mean  specific  lysis of  16.8  _+ 
0.34%)  than  the  other  members  of this  group  (p  <  0.0001).  However,  these i 
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FIGURE 2.  Cold-target blocking experiments of CTL generated against measles virus (MV) 
from MS patient 8 (A) and normal individual 17 (B) were performed as described in Material 
and  Methods.  Percent  specific lysis  is  plotted  vs.  increasing cold/hot targets.  Open  circles 
represent uninfected autologous B cell lines, and filled circles represent measles virus-infected 
autologous targets. Effector/hot target ratio is 40:1. 
sensitized  lymphocytes lysed their  uninfected autologous B cell line at a  mean 
level of lysis of 17.7 +  3.3 %. This indicated a non-measles virus-specific response 
in PBL stimulated with measles virus from these three MS patients.  None of the 
normal individuals or ODC who had higb levels of lysis on measles virus-infected 
autoiogous  B  cell  lines  significantly  lysed  their  uninfected  autologous  B  cell 
targets (data not shown). To confirm this apparent lack of measles virus-specific 
killing in the MS patients who had high levels of lysis on uninfected autologous 
B cell targets, cold-target blocking experiments were performed. The results of 
a  representative  experiment are shown in  Fig.  2.  The ability of measles virus- 
stimulated  PBL  from  normal  individual  17  to  lyse  the  ~Cr-labelled  measles 
virus-infected autologous B cell line could only be blocked by increasing numbers 
of unlabelled cold measles virus-infected B cell targets, and not by the addition 
of cold uninfected  cells.  In  contrast,  the  capacity of measles  virus-stimulated 
PBL from MS patient 8 to lyse its infected, 5tCr-labelled B cell target could be 
blocked by both infected and uninfected autologous B cell lines (Fig. 2A). This 
result showed that there is a  non-measles virus-specific lysis by measles virus- 
stimulated PBL from this MS patient. 
Susceptibility of MS Patients Measles  Virus-infected  B  Cell Lines to Be Lysed  by 
Measles  Virus-specific  CTL.  The  possibility  that  the  lowered  measles  virus- 
specific CTL responses from MS patients was due to the inability of MS patients 
B  cell  lines  to functionally express measles virus antigens  was next examined. JACOBSON  ET  AL. 
TABLE  II 
Susceptibility of Measles Virus-infected B Cell Lines from MS Patients to Lysis 
by CTL Generated  from Normal Individuals 
845 
Exp.  Measles virus-stimu-  Percent lysis of measles virus-infected 
lated effectors*  B cell targets* 
MS patient 2  MS patient 7  Normal 15 
It 
MS patient 2  4.3  NT  -10.9 
MS patient 7  NT  -4.9  NT 
Normal 15  16.0  21.5  24.2 
MS patient 16  Normal 12  Normal 13 
MS patient 16  1.3  NT  NT 
Normal 12  22.5  22.1  32.4 
Normal 13  15.4  16.8  30.1 
MS patient 1  Normal 12 
III  MS patient 1  5.9  NT 
Normal 12  15.2  24.6 
* Effectors were generated from the indicated individual by a 7-d in vitro stimulation 
of PBL with measles virus, as described in Materials and Methods. Effectors were 
used at an effector/target ratio of 40:1. 
* Data are presented as percent lysis of measles virus-infected B cell line targets, as 
described in Materials and Methods. NT, not tested. 
Initially,  the  expression  of measles  virus  from  infected  B  cell  lines  from  MS 
patients  and  normal  individuals  was  examined  by fluorescent  antibody  tech- 
niques,  using  a  fluorescein-conjugated  serum  from  a  patient  with  subacute 
sclerosing panencephalitis  (11). The intensity of staining and percent of positive 
cells  was  similar  in  the  two  populations  (data  not  shown).  To  more  clearly 
eliminate the possibility of differences in target cell susceptibility, the ability of 
measles  virus-specific  CTL  from  normal  individuals  to  lyse  measles  virus- 
infected B cell lines from MS patients was examined (Table II). Those measles 
virus-infected B cell lines from MS patients that could not be lysed by measles 
virus-stimulated  autologous  PBL  were shown  to be susceptible to  CTL  from 
class II  HLA-matched  normal  individuals.  This  indicated  that  the diminished 
measles virus CTL responses from MS patients was not due to a failure to express 
measles virus antigen on target cell membranes. 
Discussion 
Both immunological  and  infectious mechanisms  have been suggested in  the 
etiology of MS (1,  2).  In  support of an infectious agent in the pathogenesis of 
this disorder,  evidence has been obtained from both epidemiological (12) data 
and  serological  studies.  The  latter  experiments  have  demonstrated  elevated 
serum  and  cerebrospinal  fluid  antibody  levels  to  a  number  of viruses,  most 
notably to measles virus in patients with MS (7, 8).  Since the report in  1962 by 
Adams and Imagawa (7), this specific increased antibody production to measles 
virus from  patients  with  MS  has  been  confirmed by other  laboratories  (6,  8). 
The  demonstration  of an antigen-specific  cellular  immune abnormality  in  MS 846  MEASLES  VIRUS-SPECIFIC  CTL  IN  MULTIPLE  SCLEROSIS 
has been less clear. While there is evidence to suggest that the cellular immune 
response  to  measles  virus  is  altered  in  MS  (13,  14),  this  has  not  been  well 
confirmed (15-17). 
Other  types of immune  abnormalities  have been  reported  in  MS, and  have 
been extensively reviewed (1,  2, 4).  These studies are based largely on experi- 
ments  that  have  shown  changes  in  circulating  lymphocyte subsets during  the 
course of the disease, the presence of specific lymphocyte subpopulations in CNS 
lesions,  and  alterations  of antigen  nonspecific  in  vitro  lymphocyte  functions. 
What clearly has been lacking is the demonstration of an antigen-specific cellular 
immune abnormality in MS. The importance of analyzing antigen-specific events 
is  the  possibility  that  the  antigen  under  investigation  may  be  related  to  the 
disease,  and  that  such  antigen-specific  systems  provide  greater  sensitivity  in 
examining alterations in immunoregulatory mechanisms in MS. A previous study 
of twins with MS has shown an enhanced proliferative response to measles virus 
in  the  affected member  of some discordant  twin  sets (18).  This  has  not been 
shown in the vast majority of sporadic  MS in nontwins (15-17),  nor could this 
be demonstrated in our MS population  sample (data not shown). An enhanced 
proliferative response to measles virus in a limited set of MS twins may reflect a 
different disease  mechanism  in  this unique  population,  or could be related  to 
twinning.  Because of these and other findings (13), we have been interested in 
defining measles virus-specific lymphocyte functions.  Recently, we have shown 
that measles virus-specific, OKT4 + CTL clones recognize measles virus antigen 
in association with HLA class II  molecules (9,  10).  In subsequent experiments, 
we have shown that  measles virus-specific CTL generated  in bulk culture are 
also  restricted  predominantly  to  HLA  class  II  determinants,  while  influenza 
virus-specific CTL generated  in bulk culture could be both HLA class I- and 
II-restricted (Jacobson, S., M. L. Flerlage, and H. F. McFarland,  manuscript in 
preparation) 2. 
In this study, the capacity of MS patients  (relative to normal  individuals and 
ODC) to generate measles virus- and influenza virus-specific CTL in a standard 
7-d in  vitro-stimulated  culture  system assay has  been examined.  CTL  targets 
were generated  by infection  of autologous lymphoblastoid  B  cell  lines.  These 
targets  express  both  HLA  class  I  and  class  II  antigens,  and  are  an  essential 
feature  of this  assay  system  to  detect  measles  virus-specific,  HLA  class  II- 
restricted CTL.  The  K562 line was used to assess NK activity from these 7-d- 
stimulated bulk cultures. 
The major finding in this study was that measles virus-specific CTL responses 
were  markedly  diminished  in  patients  with  MS.  The  mean  specific  lysis  of 
autologous measles virus-infected B cells for this group was 6.0 _+  1.4%,  while 
normal individuals and ODC could generate measles virus-specific CTL and lyse 
their respective infected B cell targets at a  group mean level of lysis of 26.9 + 
2.86% and 26.7 _+ 2.8%, respectively. Importantly, this diminished CTL response 
was specific for  measles virus,  since  it  could be shown that  this  group  of MS 
patients had comparable levels of influenza virus CTL and NK response  s, as did 
a panel of normal individuals and ODC. The lowered measles virus-specific CTL 
responses observed in MS patients was disease-specific, since patients with other JACOBSON ET  AL.  847 
disorders had  measles virus CTL responses comparable  to normal  individuals. 
No correlation  could be made with the diminished  measles virus CTL activity 
and the disability status of this group of MS patients (Table I). Further, patients 
with other diseases and moderately severe disability did not show a reduction in 
measles virus-specific CTL responses. Although three MS patients in this study 
did lyse their measles virus-infected autologous B cell targets at somewhat higher 
levels than the majority of MS patients tested (Fig.  1 A, asterisks), they also lysed 
their uninfected B cell targets at comparable levels. Lysis of uninfected cells by 
in  vitro-primed  lymphocytes  was  indicative  of a  non-measles  virus-specific 
event, and cold-target blocking experiments confirmed this (Fig.  2).  When this 
is taken  into consideration  in  the interpretation  of these data,  the observation 
on  these  three  MS patients  also supports  the  concept that  measles virus  CTL 
responses are decreased in MS. 
The evidence presented in this report couples two hypotheses in the pathogen- 
esis of MS: (a) There  is an infectious agent that may be an etiological factor in 
this  disorder;  and  (b)  There  is  an  ongoing  immune  dysfunction  that  may  be 
related to the infectious agent. The demonstration of diminished measles virus- 
specific CTL activity suggests a  number of possible interpretations.  If measles 
virus-specific CTL are absent or in lower numbers in the peripheral blood, one 
possibility is  that  these  cells  may be  sequestered  in  other  areas.  As  has  been 
suggested previously, MS may be due to antigen-specific  lymphocytes that  mi- 
grate to the CNS and destroy white matter (19).  Although an infiltration  of T 
cells surrounding  MS plaque lesions has been demonstrated in several laborato- 
ries (19-21), there is conflicting evidence with respect to the phenotype of these 
T  cells. Observations from one group have indicated a predominance of OKT4 + 
cells,  suggesting  a  role  for this  subpopulation  of T  cells  in  MS plaque  lesion 
development (19, 21). Our results are also of interest with respect to the recent 
studies (22) in murine experimental  allergic encephalomyelitis, a  disease model 
with pathological  and  clinical  similarities  to MS,  that  show a  redistribution  of 
Lyt-1 + lymphocytes (the murine equivalent to OKT4 ÷ cells in humans) from the 
periphery to the CNS. We have evidence that demonstrates that the majority of 
effector CTL generated in bulk culture from normal individuals are OKT4 ÷ and 
recognize measles virus in association with  HLA class II molecules (manuscript 
in preparation) 2. There is no evidence for decreased OKT4  ÷ cells in the periph- 
eral blood from MS patients in this (data not shown) or other studies (23). 
Other mechanisms  that could account for the diminished  measles virus CTL 
response in  MS deserve consideration.  First,  several lines of evidence indicate 
that the parameters of immunization  can determine the nature of the resulting 
immune response (24). Intravenous inoculation of haptenated cells will initiate a 
CTL  response  but  suppress a  delayed-type hypersensitivity  response.  In  some 
cases, these differences may be due to selective induction of suppressor cells. As 
suggested (13), a measles virus infection could eliminate a clone of measles virus- 
reactive  cells  (OKT4  +  CTL?),  which  may  result  in  a  suppression  of cellular 
reactivity  to  this  agent.  Consequently,  differences  between  MS  patients  and 
controls during the initial  immunization  to measles virus could account for our 848  MEASLES  VIRUS-SPECIFIC  CTL  IN  MULTIPLE  SCLEROSIS 
findings.  These differences could include age when exposed, strain of virus, or 
severity of infection. 
A  second consideration  is that our findings could reflect a  specific reduction 
in OKT4 + cytotoxic cells. The major portion of influenza virus-specific CTL is 
HLA class  I-restricted,  and  would not be affected by such a  mechanism.  Al- 
though  there  was  no  evidence  for  an  overall  reduction  in  OKT4 +  cells,  a 
reduction  in  a  subset of this  population  with  CTL  function  may occur.  This 
possibility cannot be excluded until  other examples of HLA class II-restricted 
killing are examined.  Alternatively, an increase in suppressor cells (presumably 
with an OKT8 + phenotype) could also serve to selectively reduce measles virus- 
specific CTL.  Although  we saw no increase in  OKT8 + cells in  the peripheral 
blood from  the  MS  patients  we  studied,  functional  assays  for  measles  virus- 
specific suppressor cells would be required to resolve this possibility. 
As suggested previously (1),  it may not be possible, in a  single hypothesis, to 
account for all the observations that have been reported in studies of MS. Indeed, 
MS may be a  heterogeneous  disorder,  with  various etiologies, and  more than 
one pathogenic mechanism.  More MS patients in different stages of the disease 
with varying degrees of disability must be examined for their  cellular immune 
responses to a number of infectious agents. 
Summary 
To assess whether  an  virus-specific  immune  defect may be associated with 
multiple sclerosis (MS), we have examined the ability to generate measles virus- 
and influenza virus-specific cytotoxic T  cells (CTL) in patients with MS, normal 
individuals, and other disease controls (ODC). The mean (_ SEM) measles virus- 
specific CTL response for normal individuals and ODC was 26.9 +_ 2.9%  (N -- 
17) and 26.7 _+ 2.8% (N =  13) specific lysis, respectively. In contrast, the capacity 
of MS patients to generate measles virus-specific CTL was markedly diminished. 
Peripheral  blood lymphocytes from  MS patients  stimulated  with measles virus 
lysed their measles virus-infected autologous B cell line at a group mean level of 
6.0 _+  1.4%  (N =  16) specific lysis.  MS patients  had significantly lower measles 
virus-specific CTL responses than normal individuals (p <  0.00001) or ODC (p 
<  0.0001).  Importantly,  this  lowered  response  did  not  reflect  a  generalized 
depressed cytolytic activity of MS patients,  since influenza  virus-specific  CTL 
and  NK  activity  from  these  patients  were  comparable  to  normals  and  ODC. 
Thus, in MS there is a significant depression of measles virus-specific CTL which 
suggests  that  this  virus-specific  immune  dysfunction  may  play  a  role  in  the 
pathogenesis of this disorder. 
We thank Dr. A. Goodman for his assistance in obtaining ODC samples, and Drs. Goodman 
and D. McFarlin for their helpful comments. 
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